FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Terasaki

Research Profile

Physiology

Procedures

Living Beings

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Tissue and Organ Procurement

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Hugo Kaneku; Jacqueline G O'Leary; Brian M Susskind; Michiko Taniguchi; Paul I Terasaki; Göran B Klintmalm
Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.
Junichi Hoshino; Hugo Kaneku; Matthew Everly; Sander Greenland; Paul I Terasaki
Using donor-specific antibodies to monitor the need for immunosuppression.
Paul I Terasaki
A personal perspective: 100-year history of the humoral theory of transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Terasaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Hugo Kaneku; Jacqueline G O'Leary; Brian M Susskind; Michiko Taniguchi; Paul I Terasaki; Göran B Klintmalm
Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012;18(8):984-92.
2012: Junichi Hoshino; Hugo Kaneku; Matthew Everly; Sander Greenland; Paul I Terasaki
Using donor-specific antibodies to monitor the need for immunosuppression.
Transplantation 2012;93(11):1173-8.
2012: Paul I Terasaki
A personal perspective: 100-year history of the humoral theory of transplantation.
Transplantation 2012;93(8):751-6.
2011: Paul I Terasaki
Cold ischemia time--time to rethink the risk for kidneys?
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2011;11(12):2551-2.
2009: Po-Chang Lee; Lan Zhu; Paul I Terasaki; Matthew Everly
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
Transplantation 2009;88(4):568-74.
2007: Richard J Glassock; Paul I Terasaki
The origins of collaborative organ salvaging and sharing: Los Angeles, 1967.
Clinical transplants 2007;():289-93.
2002: Po-Chang Lee; Paul I Terasaki; Steven K Takemoto; Po-Huang Lee; Chung-Jye Hung; Yi-Lin Chen; Alen Tsai; Huan-Yao Lei
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies.
Transplantation 2002;74(8):1192-4.
2000: Steven K Takemoto; Paul I Terasaki; David W Gjertson; J Michael Cecka
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation.
The New England journal of medicine 2000;343(15):1078-84.
2000: Paul I Terasaki
Longmire lecture: my 50 years at the University of California, Los Angeles.
World journal of surgery 2000;24(7):828-33.
1999: YW Cho; J Michael Cecka; D W Gjertson; Paul I Terasaki
Prolonged hypertension (> 10 years) is a significant risk factor in older cadaver donor renal transplants.
Transplantation proceedings 1999;31(1-2):1283.
1999: Steven K Takemoto; J Michael Cecka; David W Gjertson; Paul I Terasaki
Class I peptides involved in the indirect pathway of allorecognition.
Transplantation proceedings 1999;31(1-2):781.
1999: Melinda A Maggard; C Johnson; T Wang; Paul I Terasaki; Jerzy W Kupiec-Weglinski; Ronald W Busuttil; David K Imagawa
Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response.
Transplantation proceedings 1999;31(1-2):728-9.
1999: Paul I Terasaki
History of some currently utilized procedures in transplantation.
Transplantation proceedings 1999;31(1-2):47-8.
1999: Paul I Terasaki; S Takemoto
Impact of HLA system on organ transplantation: a critical review before the end of the millennium.
Advances in nephrology from the Necker Hospital 1999;29():163-75.
1998: YW Cho; Paul I Terasaki; J Michael Cecka
High kidney graft survival rates using non-heart-beating trauma donors.
Transplantation proceedings 1998;30(7):3795-6.
1998: Po-Chang Lee; Po-Huang Lee; CK Shaw; Steven K Takemoto; David W Gjertson; P A Siauw; Paul I Terasaki
HLA epitopes for kidney allocation.
Transplantation proceedings 1998;30(7):3496-7.
1998: Y Hata; J Michael Cecka; S Takemoto; M Ozawa; Yong W Cho; Paul I Terasaki
Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients.
Transplantation 1998;65(2):208-12.
1998: Paul I Terasaki; J Michael Cecka; David W Gjertson
Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation.
Clinical transplants 1998;():437-41.
1998: Paul I Terasaki; J Michael Cecka
A gold medal for organ donors and donor families.
Clinical transplants 1998;():348.
1997: Paul I Terasaki; David W Gjertson; J Michael Cecka; S Takemoto; Yong W Cho
Significance of the donor age effect on kidney transplants.
Clinical transplantation 1997;11(5 Pt 1):366-72.
1997: Steven K Takemoto; Paul I Terasaki
Evaluation of the transplant recipient and donor: molecular approach to tissue typing, flow cytometry and alternative approaches to distributing organs.
Current opinion in nephrology and hypertension 1997;6(3):299-303.
1997: Steven K Takemoto; J Michael Cecka; Paul I Terasaki
Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts.
Transplantation proceedings 1997;29(1-2):1417.
1997: Paul I Terasaki
1996 Medawar Prize Lecture.
Transplantation proceedings 1997;29(1-2):33-8.
1997: J Michael Cecka; Paul I Terasaki
Living donor kidney transplants: superior success rates despite histoincompatibilities.
Transplantation proceedings 1997;29(1-2):203.
1997: YW Cho; Paul I Terasaki; J Michael Cecka; David W Gjertson; S Takemoto
Should excessive height and weight differences between the kidney donor and recipient be avoided?
Transplantation proceedings 1997;29(1-2):104-5.
1996: Maria Bettinotti; Y Mitsuishi; M Lau; H Silver; A Spence; Paul I Terasaki
HLA-A* 1104: a new allele found in a Laotian family.
Tissue antigens 1996;48(6):717-9.
1996: Paul I Terasaki; M Cecka; D Gjertson; S Takemoto
Allocation of cadaver kidneys.
Lancet 1996;348(9036):1247.
1996: J A Kobashigawa; A Sabad; D Drinkwater; G A Cogert; Jaime Moriguchi; N Kawata; Michele A Hamilton; Antoine Hage; Paul I Terasaki; Hillel Laks
Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?
Circulation 1996;94(9 Suppl):II294-7.
1996: David K Imagawa; Sherfield Sherfield Dawson; Curtis D Holt; P S Kirk; Fady Kaldas; Christopher Shackleton; Philip Seu; SM Rudich; Milan Kinkhabwala; Paul Martin; Leonard I Goldstein; N G Murray; Paul I Terasaki; Ronald W Busuttil
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
Transplantation 1996;62(7):934-42.
1996: Sherfield Sherfield Dawson; David K Imagawa; C Johnson; M Cecka; Paul I Terasaki; Christopher Shackleton; Ronald W Busuttil
UCLA liver transplantation: analysis of immunological factors affecting outcome.
Artificial organs 1996;20(10):1063-72.
1996: Paul I Terasaki; David W Gjertson; J Michael Cecka; Steven K Takemoto
Fit and match hypothesis for kidney transplantation.
Transplantation 1996;62(4):441-5.
1996: M Hirata; Paul I Terasaki; Y W Cho
Cytomegalovirus antibody status and renal transplantation: 1987-1994.
Transplantation 1996;62(1):34-7.
1996: Y W Cho; Paul I Terasaki
Comparison of kidney graft survival in Asian and Caucasian patients transplanted in the United States.
Transplantation proceedings 1996;28(3):1571-3.
1996: Steven K Takemoto; Paul I Terasaki
HLA compatibility can be predicted by matching only three residues with outward oriented sidechains.
Transplantation proceedings 1996;28(3):1264-6.
1996: Paul I Terasaki; Y Cho; Steven K Takemoto; M Cecka; David W Gjertson
Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival.
Transplantation proceedings 1996;28(3):1144-5.
1996: M Hirata; Y W Cho; J Michael Cecka; Paul I Terasaki
Patient death after renal transplantation--an analysis of its role in graft outcome.
Transplantation 1996;61(10):1479-83.
1996: Paul I Terasaki; J Michael Cecka; David W Gjertson; Steven K Takemoto; Y W Cho; J Yuge
Risk rate and long-term kidney transplant survival.
Clinical transplants 1996;():443-58.
1995: David W Gjertson; J Michael Cecka; Paul I Terasaki
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.
Transplantation 1995;60(12):1384-8.
1995: J A Kobashigawa; SA Katznelson; Hillel Laks; J A Johnson; L Yeatman; X M Wang; D Chia; Paul I Terasaki; A Sabad; G A Cogert
Effect of pravastatin on outcomes after cardiac transplantation.
The New England journal of medicine 1995;333(10):621-7.
1995: Paul I Terasaki; J Michael Cecka; David W Gjertson; Steven K Takemoto
High survival rates of kidney transplants from spousal and living unrelated donors.
The New England journal of medicine 1995;333(6):333-6.
1995: J M Weisz; Gary N Holland; L N Roer; M S Park; A J Yuge; R S Moorthy; D J Forster; Narsing A Rao; Paul I Terasaki
Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
Ophthalmology 1995;102(7):1012-5.
1995: J Michael Cecka; Paul I Terasaki
Optimal use for older donor kidneys: older recipients.
Transplantation proceedings 1995;27(1):801-2.
1995: D Chia; Paul I Terasaki; A Acalinovich; H Chan; R Balan
HLA DR typing by polymerase chain reaction in Terasaki trays.
Transplantation proceedings 1995;27(1):696-7.
1995: Steven K Takemoto; David W Gjertson; J Michael Cecka; Paul I Terasaki
HLA matching for local pools using fewer HLA factors.
Transplantation proceedings 1995;27(1):675-7.
1995: David W Gjertson; Steven K Takemoto; J Michael Cecka; Paul I Terasaki
Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching.
Transplantation proceedings 1995;27(1):653-5.
1995: Paul I Terasaki; David W Gjertson; J Michael Cecka; Steven K Takemoto
Proposed HLA matching scheme for improved cadaveric kidney allocation.
Transplantation proceedings 1995;27(1):61-3.
1995: Paul I Terasaki; J D McClelland; J Yuge; J Michael Cecka; David W Gjertson; Steven K Takemoto; Y W Cho
Advances in kidney transplantation: 1985-1995.
Clinical transplants 1995;():487-501.
1995: Y W Cho; Paul I Terasaki; J Michael Cecka
New variables reported to the UNOS registry and their impact on cadaveric renal transplant outcomes - a preliminary study.
Clinical transplants 1995;():405-15.
1995: J Michael Cecka; Paul I Terasaki
The UNOS scientific renal transplant registry. United Network for Organ Sharing.
Clinical transplants 1995;():1-18.
1994: D Chia; Paul I Terasaki; H Chan; A Acalinovich; E Maruya; H Saji; K Ware
A new simplified method of gene typing.
Tissue antigens 1994;44(5):300-5.
1994: Steven K Takemoto; Paul I Terasaki; David W Gjertson; J Michael Cecka
Equitable allocation of HLA-compatible kidneys for local pools and minorities.
The New England journal of medicine 1994;331(12):760-4.
1994: Steven K Takemoto; Paul I Terasaki
Comparison of HLA matching protocols to maximize the number of compatible kidney recipients in small Asian pools.
Transplantation proceedings 1994;26(4):1879-80.
1994: Paul I Terasaki; H Koyama; J Michael Cecka; David W Gjertson
The hyperfiltration hypothesis in human renal transplantation.
Transplantation 1994;57(10):1450-4.
1994: H Koyama; J Michael Cecka; Paul I Terasaki
Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival.
Transplantation 1994;57(7):1064-8.
1994: K Ogura; Paul I Terasaki; H Koyama; J Chia; David K Imagawa; Ronald W Busuttil
High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients.
Clinical transplantation 1994;8(2 Pt 1):111-5.
1994: J Michael Cecka; Paul I Terasaki
Repeating HLA antigen mismatches in renal retransplants--a second class mistake?
Transplantation 1994;57(4):515-9.
1994: Paul I Terasaki; J Yuge; J Michael Cecka; David W Gjertson
Cytomegalovirus antibody status and kidney transplantation.
Clinical transplants 1994;():509-18.
1993: D Chia; Paul I Terasaki; H Chan; R Tonai; P A Siauw
Direct detection of PCR products for HLA class II typing.
Tissue antigens 1993;42(3):146-9.
1993: S Koyama; Y Mitsuishi; K Bibee; I Watanabe; Paul I Terasaki
HLA associations with Menière's disease.
Acta oto-laryngologica 1993;113(5):575-8.
1993: J Michael Cecka; David W Gjertson; Y Cho; Paul I Terasaki
HLA polymorphisms, ethnicity, and graft survival: united network for organ sharing. UNOS Scientific Renal Transplant Registry.
Transplantation proceedings 1993;25(4):2446-7.
1993: K Ogura; Paul I Terasaki; C Johnson; R Mendez; J T Rosenthal; R Ettenger; D C Martin; E Dainko; L Cohen; T Mackett
The significance of a positive flow cytometry crossmatch test in primary kidney transplantation.
Transplantation 1993;56(2):294-8.
1993: X M Wang; Paul I Terasaki; G W Rankin; D Chia; H P Zhong; S Hardy
A new microcellular cytotoxicity test based on calcein AM release.
Human immunology 1993;37(4):264-70.
1993: Prasad S Koka; D Chia; Paul I Terasaki; H Chan; J Chia; M Ozawa; E Lim
The role of IgA anti-HLA class I antibodies in kidney transplant survival.
Transplantation 1993;56(1):207-11.
1993: E C Lim; D Chia; D W Gjertson; Prasad S Koka; Paul I Terasaki
In vitro studies to explain high renal allograft survival in IgA nephropathy patients.
Transplantation 1993;55(5):996-9.
1993: Steven K Takemoto; J Michael Cecka; David W Gjertson; Paul I Terasaki
Six-antigen-matched transplants. Causes of failure.
Transplantation 1993;55(5):1005-8.
1993: J Michael Cecka; David W Gjertson; Paul I Terasaki
Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups?
Transplantation proceedings 1993;25(1 Pt 1):548-9.
1993: K Ogura; H Koyama; Steven K Takemoto; J Chia; C Johnson; Paul I Terasaki
Flow cytometry crossmatching for kidney transplantation.
Transplantation proceedings 1993;25(1 Pt 1):245-6.
1993: David W Gjertson; Paul I Terasaki; J Michael Cecka; Steven K Takemoto
Reduction of the center effect by HLA matching.
Transplantation proceedings 1993;25(1 Pt 1):215-6.
1993: Steven K Takemoto; Paul I Terasaki; E Maruya; M S Park
Molecular matching for clinical kidney transplantation.
Transplantation proceedings 1993;25(1 Pt 1):206.
1993: Paul I Terasaki; J Yuge; J Michael Cecka; David W Gjertson; Steven K Takemoto; Y Cho
Thirty-year trends in clinical kidney transplantation.
Clinical transplants 1993;():553-62.
1993: E Maruya; Steven K Takemoto; Paul I Terasaki
HLA matching: identification of permissible HLA mismatches.
Clinical transplants 1993;():511-20.
1993: J Michael Cecka; Paul I Terasaki
The UNOS Scientific Renal Transplant Registry.
Clinical transplants 1993;():1-18.
1992: A Yanagiya; Paul I Terasaki; Y Iwaki; B B Ho; D C Drinkwater; H Laks
Prolongation of second heart transplants in rats.
Transplantation 1992;54(4):690-4.
1992: Y Mitsuishi; Paul I Terasaki
HLA matching effect on five-year graft survival and half-life in the cyclosporine era.
Kidney international. Supplement 1992;38():S172-5.
1992: Steven K Takemoto; Paul I Terasaki; J Michael Cecka; Y W Cho; David W Gjertson
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
The New England journal of medicine 1992;327(12):834-9.
1992: K Ogura; H Koyama; Steven K Takemoto; Paul I Terasaki; Ronald W Busuttil
Significance of a positive crossmatch on outcome in human liver transplantation.
Transplantation proceedings 1992;24(4):1465.
1992: J Michael Cecka; David W Gjertson; Paul I Terasaki
Superior renal allograft survival among Asian recipients.
Transplantation proceedings 1992;24(4):1431-2.
1992: Steven K Takemoto; E Carnahan; Paul I Terasaki
Beneficial effect of sharing six-antigen-matched cadaver kidneys in the United States.
Transplantation proceedings 1992;24(4):1310-1.
1992: Steven K Takemoto; Paul I Terasaki; M S Park; B D Clark
Effect of mismatching serologically defined residues on kidney transplant survival.
Transplantation proceedings 1992;24(4):1266-8.
1992: Y Sameshima; D Chia; Paul I Terasaki; David K Imagawa; Ronald W Busuttil
Appearance of the tumor marker CA 19-9 in liver transplant patients during rejection episodes.
Transplantation 1992;53(3):580-2.
1992: David W Gjertson; Paul I Terasaki
The large center variation in half-lives of kidney transplants.
Transplantation 1992;53(2):357-62.
1992: J Michael Cecka; Y W Cho; Paul I Terasaki
Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success.
Transplantation 1992;53(1):59-64.
1992: Sue V McDiarmid; Ronald W Busuttil; Paul I Terasaki; Jorge H Vargas; Marvin E Ament
OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients.
Journal of pediatric gastroenterology and nutrition 1992;14(1):86-91.
1991: Sue V McDiarmid; M J Millis; Paul I Terasaki; Marvin E Ament; Ronald W Busuttil
OKT3 prophylaxis in liver transplantation.
Digestive diseases and sciences 1991;36(10):1418-26.
1991: Steven K Takemoto; Paul I Terasaki
HLA peptide matching.
Transplantation proceedings 1991;23(4):2039-42.
1991: Y Kato; Y Mitsuishi; M Cecka; J Hopfield; L Hunt; Richard Champlin; Paul I Terasaki; James L Gajewski
HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants.
Transplantation 1991;52(2):374-6.
1991: Sue V McDiarmid; Ronald W Busuttil; P Levy; M J Millis; Paul I Terasaki; Marvin E Ament
The long-term outcome of OKT3 compared with cyclosporine prophylaxis after liver transplantation.
Transplantation 1991;52(1):91-7.
1991: P Soon-Shiong; Paul I Terasaki; R P Lanza
Immunocytochemical identification of monoclonal antibodies with binding activity to acinar cells but not islets.
Pancreas 1991;6(3):318-23.
1991: David W Gjertson; Paul I Terasaki; Steven K Takemoto; M R Mickey
National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs.
The New England journal of medicine 1991;324(15):1032-6.
1991: D Chia; Paul I Terasaki; H Chan; M Ozawa
Binding of IgG to B cell via HLA molecules.
Tissue antigens 1991;37(2):49-55.
1991: K Teramoto; Angeles Baquerizo; David K Imagawa; Philip Seu; J Hart; R A Dempsey; Paul I Terasaki; N Kamada; Ronald W Busuttil
Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody.
Transplantation proceedings 1991;23(1 Pt 1):602-3.
1991: Paul I Terasaki; J Michael Cecka; Y Cho; Steven K Takemoto; M R Mickey
A report from the UNOS Scientific Renal Transplant Registry.
Transplantation proceedings 1991;23(1 Pt 1):53-4.
1991: Paul I Terasaki; Steven K Takemoto; M S Park; J Michael Cecka; M R Mickey
Molecular HLA matching.
Transplantation proceedings 1991;23(1 Pt 1):365-7.
1991: Steven K Takemoto; E Carnahan; Paul I Terasaki
A report of 504 six antigen-matched transplants.
Transplantation proceedings 1991;23(1 Pt 2):1318-20.
1991: J Cicciarelli; Paul I Terasaki
Matching cadaver transplants achieve graft survivals comparable to living related transplants.
Transplantation proceedings 1991;23(1 Pt 2):1284-8.
1991: N J Feduska; D Chia; Paul I Terasaki; L Sugich
Effect of anti-Fab antibodies on renal allografts.
Transplantation proceedings 1991;23(1 Pt 2):1277-8.
1991: Paul I Terasaki; J Michael Cecka; E Lim; Steven K Takemoto; Y Cho; David W Gjertson; K Ogura; H Koyama; Y Mitsuishi; J Yuge
UCLA and UNOS Registries. Overview.
Clinical transplants 1991;():409-30.
1990: David K Imagawa; J M Millis; Kim M Olthoff; Philip Seu; R A Dempsey; J Hart; Paul I Terasaki; E M Wasef; Ronald W Busuttil
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats.
Transplantation 1990;50(2):189-93.
1990: Sue V McDiarmid; M Millis; G Terashita; Marvin E Ament; Ronald W Busuttil; Paul I Terasaki
Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients.
Transplantation proceedings 1990;22(4):1774-6.
1990: E J Prochazka; Paul I Terasaki; M S Park; Leonard I Goldstein; Ronald W Busuttil
Association of primary sclerosing cholangitis with HLA-DRw52a.
The New England journal of medicine 1990;322(26):1842-4.
1990: David K Imagawa; J M Millis; Kim M Olthoff; Philip Seu; R A Dempsey; J Hart; Paul I Terasaki; Ronald W Busuttil
Anti-tumor necrosis factor antibody enhances allograft survival in rats.
The Journal of surgical research 1990;48(4):345-8.
1990: P Soon-Shiong; T Fujioka; Paul I Terasaki; R Heintz; R P Lanza
Islet purification by a novel immunomicrosphere cell depletion technique.
Transplantation proceedings 1990;22(2):780-1.
1990: T Fujioka; Paul I Terasaki; R Heintz; N Merideth; R P Lanza; T L Zheng; P Soon-Shiong
Rapid purification of islets using magnetic microspheres coated with anti-acinar cell monoclonal antibodies.
Transplantation 1990;49(2):404-7.
1990: Y Iwaki; J Michael Cecka; Paul I Terasaki
The transfusion effect in cadaver kidney transplants--yes or no.
Transplantation 1990;49(1):56-9.
1990: Steven K Takemoto; E Carnahan; Paul I Terasaki
Report on 604 six-antigen-matched transplants.
Clinical transplants 1990;():485-95.
1990: J Michael Cecka; Paul I Terasaki
The UNOS Scientific Renal Transplant Registry--1990.
Clinical transplants 1990;():1-10.
1990: P Soon-Shiong; R Heintz; T Fujioka; Paul I Terasaki; N Merideth; R P Lanza
Utilization of anti-acinar cell monoclonal antibodies in the purification of rat and canine islets.
Hormone and metabolic research. Supplement series 1990;25():45-50.
1989: Steven K Takemoto; Paul I Terasaki
A comparison of kidney transplant survival in white and black recipients.
Transplantation proceedings 1989;21(6):3865-8.
1989: G X Wang; G Y Terashita; Paul I Terasaki
Platelet crossmatching for kidney transplants by flow cytometry.
Transplantation 1989;48(6):959-61.
1989: H Togashi; M Ghoneum; M Takasugi; K Kasai; H Mugishima; R Billing; Paul I Terasaki
A monoclonal antibody 1A6 to T-cell recognizes a common antigen expressed on lymphocytes from normal and leukemic patients, and inhibits NK cell activity.
Hematological oncology 1989;7(3):233-42.
1989: Paul I Terasaki; M R Mickey; M Cecka; Y Iwaki; J Cicciarelli
Clinical kidney transplants, 1988.
Immunology letters 1989;21(1):33-8.
1989: P Soon-Shiong; R Heintz; Paul I Terasaki
Identification of novel blood group-reactive monoclonal antibodies cytotoxic to human acinar cells but not islets.
Transplantation proceedings 1989;21(1 Pt 3):2622-3.
1989: D Chia; Paul I Terasaki; E Casuga; M Ozawa
Influence of antimucin antibody in kidney transplantation.
Transplantation proceedings 1989;21(1 Pt 1):698-9.
1989: Y Iwaki; Paul I Terasaki; M Lau; A Yanagiya; N Feduska; D Cross; A Diethelm; B Barger; D Senitzer; J Langley
Prospective study of kidney transplantation across positive T warm crossmatches.
Transplantation proceedings 1989;21(1 Pt 1):693.
1989: J Cicciarelli; Paul I Terasaki
Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
Transplantation proceedings 1989;21(1 Pt 1):659-60.
1989: Paul I Terasaki; M R Mickey; Y Iwaki; J Cicciarelli; M Cecka; D Cook; J Yuge
Long-term survival of kidney grafts.
Transplantation proceedings 1989;21(1 Pt 1):615-7.
1989: Angeles Baquerizo; N Kamada; J M Millis; Y Iwaki; Paul I Terasaki; J Hart; C Pera; Ronald W Busuttil
Donor-specific serum transfusion prolongs survival of orthotopic liver transplantation in the rat.
Transplantation proceedings 1989;21(1 Pt 1):1179-80.
1989: M R Mickey; D J Cook; Paul I Terasaki
Recipient pool sizes for prioritized HLA matching.
Transplantation 1989;47(2):401-3.
1989: Sue V McDiarmid; D J Cook; M R Mickey; Marvin E Ament; Ronald W Busuttil; Paul I Terasaki
The development of a lymphocyte population with suppressor phenotype after successful liver transplantation.
Transplantation proceedings 1989;21(1 Pt 1):423-4.
1989: Paul I Terasaki
Beneficial effect of transfusion on kidney transplants.
Vox sanguinis 1989;57(2):158-60.
1989: H Takiff; Y Iwaki; M Cecka; Paul I Terasaki
The benefit and underutilization of sharing kidneys for better histocompatibility.
Transplantation 1989;47(1):102-5.
1989: J McClelland; Paul I Terasaki; T Berne; L P Brennan; P Bretan; A Cohen; E Dainko; Gabriel M Danovitch; R Ettenger; E Lieberman
Evaluation of the UNOS point system for kidney recipient selection.
Clinical transplants 1989;():471-6.
1989: J Michael Cecka; S Corcoran; Steven K Takemoto; Y Cho; M R Mickey; Paul I Terasaki
The UNOS Scientific Renal Transplant Registry.
Clinical transplants 1989;():1-8.
1989: Paul I Terasaki; M S Park; Steven K Takemoto; J Michael Cecka; B Clark; S Corcoran; J Cicciarelli; A Barbetti; J Yuge; E Carnahan
Overview and epitope matching.
Clinical transplants 1989;():499-516.
1988: D J Cook; Paul I Terasaki
Cyclosporine A and histocompatibility in kidney transplantation.
Transplantation proceedings 1988;20(3 Suppl 3):244-8.
1988: H Takiff; D J Cook; N S Himaya; M R Mickey; Paul I Terasaki
Dominant effect of histocompatibility on ten-year kidney transplant survival.
Transplantation 1988;45(2):410-5.
1988: H Takiff; M Novak; Y Iwaki; Paul I Terasaki
Low-dose cyclosporine maintenance therapy after immunosuppressive induction in a rat cardiac transplant model.
Transplantation 1988;45(2):297-301.
1988: P Soon-Shiong; R Heintz; Paul I Terasaki
Characterization of monoclonal antibodies CBL3 and TT62 with differing antigenic determinants specific for isolated human islets.
Biochemical and biophysical research communications 1988;150(2):775-80.
1988: J Michael Cecka; J Cicciarelli; M R Mickey; Paul I Terasaki
Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
Transplantation 1988;45(1):81-6.
1988: Paul I Terasaki; J Michael Cecka; Steven K Takemoto; J Yuge; M R Mickey; M S Park; Y Iwaki; J Cicciarelli; Y Cho
Clinical transplants 1988. Overview.
Clinical transplants 1988;():409-34.
1988: G X Wang; G Y Terashita; Paul I Terasaki
Crossmatching on platelets by flow cytometry.
Clinical transplants 1988;():381-5.
1988: D J Cook; Paul I Terasaki; Y Iwaki; G Terashita; J Fujikawa; J Gera; A Takeda; Gabriel M Danovitch; J T Rosenthal; R Fine
Flow cytometry crossmatching for kidney transplantation.
Clinical transplants 1988;():375-80.
1987: D J Cook; B Graver; Paul I Terasaki
ABO incompatibility in cadaver donor kidney allografts.
Transplantation proceedings 1987;19(6):4549-52.
1987: J Michael Cecka; S E Breidenthal; Paul I Terasaki
Low anti-A and anti-B titers in some type O patients may permit renal transplantation across the ABO barrier.
Transplantation proceedings 1987;19(6):4507-10.
1987: J Michael Cecka; Paul I Terasaki
Improvement of kidney transplant regraft results by using trauma death donors.
Transplantation 1987;44(6):792-5.
1987: R Roy; Paul I Terasaki; D Chia; M R Mickey
Low kidney graft survival in Lewis negative patients after regrafting and newer matching schemes for Lewis.
Transplantation proceedings 1987;19(6):4498-502.
1987: B D Clark; M S Park; R Tonai; Paul I Terasaki
Serologic and biochemical analysis of HLA B15 and B5 complexes.
Human immunology 1987;20(1):47-57.
1987: J M Cecka; S Breidenthal; Paul I Terasaki
Direct blood group typing of forensic samples using a simple monoclonal antibody assay.
Forensic science international 1987;34(3):205-16.
1987: Y Iwaki; D J Cook; Paul I Terasaki; M Lau; G Y Terashita; Gabriel M Danovitch; R Fine; R Ettenger; R Mendez; A Kavalich
Flow cytometry crossmatching in human cadaver kidney transplantation.
Transplantation proceedings 1987;19(1 Pt 1):764-6.
1987: M R Mickey; T V Berne; B D Kahan; O Salvatierra; T E Starzl; Paul I Terasaki
HLA matching assessed from early graft function.
Transplantation proceedings 1987;19(1 Pt 1):681-2.
1987: D J Cook; J Michael Cecka; Paul I Terasaki
HLA-DR1 recipients have the highest kidney transplant survival.
Transplantation proceedings 1987;19(1 Pt 1):675-7.
1987: H Takiff; M R Mickey; J Cicciarelli; Paul I Terasaki
Factors important in ten-year kidney graft survival.
Transplantation proceedings 1987;19(1 Pt 1):666-8.
1987: J Cicciarelli; Paul I Terasaki; M Cecka; M R Mickey
Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
Transplantation proceedings 1987;19(1 Pt 1):647-9.
1987: J Michael Cecka; J Cicciarelli; Paul I Terasaki
The effect of cyclosporine A in cadaver donor retransplants: a surprising effect of the sex of the donor.
Transplantation proceedings 1987;19(1 Pt 3):1842-4.
1987: J Tiwari; Paul I Terasaki; M R Mickey
Factors influencing kidney graft survival in the cyclosporine era: a multivariate analysis.
Transplantation proceedings 1987;19(1 Pt 3):1839-41.
1987: H Takiff; M Novak; L Yin; Y Iwaki; Paul I Terasaki
Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants.
Transplantation proceedings 1987;19(1 Pt 2):1452-4.
1987: D J Cook; Paul I Terasaki; Y Iwaki; G Terashita; A Takeda; J Fujikawa; M Lau; Gabriel M Danovitch; J T Rosenthal; R Fine
The flow cytometry crossmatch in kidney transplantation.
Clinical transplants 1987;():409-14.
1986: M Kawahara; Paul I Terasaki; D Chia; C Johnson; M Hermes; K Tokita
Use of four monoclonal antibodies to detect tumor markers.
Cancer 1986;58(9):2008-12.
1986: Paul I Terasaki; J Michael Cecka; T Berne; P Brennan; J L Cohen; E Dainko; Gabriel M Danovitch; R Ettenger; R Glassock; T Mackett
The Los Angeles Transplant Society.
Clinical transplants 1986;():61-7.
1985: M Kawahara; D Chia; Paul I Terasaki; A Roumanas; L Sugich; M Hermes; T Iguro
Detection of sialylated LewisX antigen in cancer sera using a sandwich radioimmunoassay.
International journal of cancer. Journal international du cancer 1985;36(4):421-5.
1983: H Mugishima; Paul I Terasaki; A Sueyoshi; R Billing
Human complement in treatment of bone marrow cells with monoclonal antibody.
Lancet 1983;2(8360):1194-5.
1983: T Horimi; Paul I Terasaki; D Chia; N Sasaki
Factors influencing the paradoxical effect of transfusions on kidney transplants.
Transplantation 1983;35(4):320-3.
1983: T Horimi; D Chia; Paul I Terasaki; T Matsumoto; Y Iwaki; H Takahashi
Association of B cold cytotoxins and anti-F (ab')2 antibodies with inhibition of mixed lymphocyte culture.
Japanese journal of medical science & biology 1983;36(1):11-6.
1982: D Chia; T Horimi; Paul I Terasaki; M Hermes
Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
Transplantation proceedings 1982;14(2):322-4.
1982: T Horimi; D Chia; Paul I Terasaki; G Ayoub; Y Iwaki
Association of anti-F(ab')2 antibodies with higher kidney transplant survival rates.
Transplantation 1982;33(6):603-5.